COMBINATION THERAPY COMPRISING GSPT1-DIRECTED MOLECULAR GLUE DEGRADERS AND PI3K/AKT/mTOR… Application WO-2024015855-A1 World Intellectual Property Organisation (WIPO) 18 Jan 2024